{"nct_id":"NCT02739360","title":"Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820","status":"TERMINATED","status_verified_date":"2019-01","start_date":"2016-05-04","start_date_type":"ACTUAL","primary_completion_date":"2017-12-28","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-28","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GILD"]}